Aminopropylidine diphosphonate (APD) in mild primary hyperparathyroidism: effect on clinical status. (Record no. 2194889)

MARC details
000 -LEADER
fixed length control field 01429 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250511225621.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199007s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0300-0664
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/j.1365-2265.1990.tb00869.x
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Schmidli, R S
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19900705
245 00 - TITLE STATEMENT
Title Aminopropylidine diphosphonate (APD) in mild primary hyperparathyroidism: effect on clinical status.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical endocrinology
Date of publication, distribution, etc. Mar 1990
300 ## - PHYSICAL DESCRIPTION
Extent 293-300 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Blood Pressure
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Calcium
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diphosphonates
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hyperparathyroidism
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Muscles
General subdivision physiopathology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pamidronate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Randomized Controlled Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Single-Blind Method
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wilson, I
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Espiner, E A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Richards, A M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Donald, R A
773 0# - HOST ITEM ENTRY
Title Clinical endocrinology
Related parts vol. 32
-- no. 3
-- p. 293-300
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/j.1365-2265.1990.tb00869.x">https://doi.org/10.1111/j.1365-2265.1990.tb00869.x</a>
Public note Available from publisher's website

No items available.